Tag: Therapy & Procedures: Misc.
CYP2C19 Genotyping May Aid Antiplatelet Prescribing
Benefit only seen for composite outcome, not for major or minor bleeding incidents
No Proof Convalescent Plasma Effective Against COVID-19
NIH panel says data are insufficient to recommend either for or against the use of convalescent plasma
WHO: Plasma Therapy for COVID-19 Still Experimental
FDA 'emergency use authorization' does not mean plasma therapy has been proven safe and effective
FDA Approves Wider Use of Plasma as COVID-19 Treatment
President Donald Trump announced emergency approval as 'breakthrough' treatment during a news briefing Sunday
FDA Emergency Approval on Hold for Blood Plasma to Treat COVID-19
More data are under review; the approval could still be issued in the near future
Evidence Poor for Accuracy of Serological Tests for COVID-19
Evidence for diagnostic accuracy of serological tests characterized by high risks of bias, heterogeneity
Convalescent Plasma Safe for Diverse Patients With COVID-19
Incidence of SAEs, including transfusion reactions, thromboembolic or thrombotic events, is low
Treatment Gap Remains in Stroke Care Between Men and Women
Size of this difference has narrowed compared with studies published before 2008
Pneumonia Risk Down With Nitrogen-Containing Bisphosphonates
Reductions in risk for pneumonia and pneumonia mortality seen among patients with hip fracture
Human Trial of Antibody Therapy to Treat COVID-19 Underway
If drug proves safe and effective, it could be available for use by the fall
